Molecular classification and correlates in colorectal cancer

被引:357
作者
Ogino, Shuji [1 ,3 ]
Goel, Ajay [2 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Baylor Univ, Med Ctr, Dept Internal Med, Dallas, TX USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.2353/jmoldx.2008.070082
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Molecular classification of colorectal cancer is evolving. As our understanding of colorectal carcinogenesis improves, we are incorporating new knowledge into the classification system. In particular, global genomic status [microsatellite instability (MSI) status and chromosomal instability (CIN) status] and epigenomic status [CpG island methylator phenotype (CIMP) status] play a significant role in determining clinical, pathological and biological characteristics of colorectal cancer. in this review, we discuss molecular classification and molecular correlates based on MSI status and CIMP status in colorectal cancer. Studying molecular correlates is important in cancer research because it can 1) provide clues to pathogenesis, 2) propose or support the existence of a new molecular subtype, 3) alert investigators to he aware of potential confounding factors in association studies, and 4) suggest surrogate markers in clinical or research settings.
引用
收藏
页码:13 / 27
页数:15
相关论文
共 129 条
  • [1] Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement
    Abdel-Rahman, WM
    Katsura, K
    Rens, W
    Gorman, PA
    Sheer, D
    Bicknell, D
    Bodmer, WF
    Arends, MJ
    Wyllie, AH
    Edwards, PAW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) : 2538 - 2543
  • [2] DNA methylation in breast and colorectal cancers
    Agrawal, Anshu
    Murphy, Richard F.
    Agrawal, Devendra K.
    [J]. MODERN PATHOLOGY, 2007, 20 (07) : 711 - 721
  • [3] Molecular diagnosis of mast cell disorders - A Paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology
    Akin, Cem
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (04) : 412 - 419
  • [4] Histopathological identification of colon cancer with microsatellite instability
    Alexander, J
    Watanabe, T
    Wu, TT
    Rashid, A
    Li, SA
    Hamilton, SR
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (02) : 527 - 535
  • [5] Colorectal cancer "Methylator phenotype": Fact or artifact?'
    Anacleto, C
    Leopoldino, AM
    Rossi, B
    Soares, FA
    Lopes, A
    Rocha, JCC
    Caballero, O
    Camargo, AA
    Simpson, AJG
    Pena, SDJ
    [J]. NEOPLASIA, 2005, 7 (04): : 331 - 335
  • [6] [Anonymous], CARCINOMA COLON RECT
  • [7] Molecular diagnostic approach to non-Hodgkin's lymphoma
    Arber, DA
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2000, 2 (04) : 178 - 190
  • [8] Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines
    Arnold, CN
    Goel, A
    Boland, CR
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (01) : 66 - 73
  • [9] Development of a fluorescent multiplex assay for detection of MSI-high tumors
    Bacher, JW
    Flanagan, LA
    Smalley, RL
    Nassif, NA
    Burgart, LJ
    Halberg, RB
    Megid, WMA
    Thibodeau, SN
    [J]. DISEASE MARKERS, 2004, 20 (4-5) : 237 - 250
  • [10] Bagg A, 1999, AM J CLIN PATHOL, V112, pS76